Why Joint Pain May Occur During GLP-1 Treatment Rapid weight loss altering joint biomechanics is the most likely indirect cause of joint pain during GLP-1 treatment, rather than a direct drug effect
On the basis of liraglutide, semaglutide replace Lys with Arg at 34 position, replace Ala with 2-aminoisobutyric acid (AIB) at 8 position, and conjugate Lys with 18 carbon fatty acid chain at 18 position
By boosting lipolysis, semaglutide facilitates the utilization of storred energy, aiding in weight loss effeorts
Awano N, Wada M, Mori H, Nakamori S, Takagi H
Tirzepatide works by activating both GLP-1 and GIP receptors in the brain, reducing hunger signals and calorie intake by an average of 500-700 calories daily